News
- 11.03.25
UniQure and FDA No Longer in Alignment on Approval Pathway for AMT-130 - 10.23.25
Additional Clarity: What We Know 4 Weeks After the uniQure News - 09.24.25
UniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease - 04.07.24
San Francisco Bay Area Affiliate Becomes a HDSA Chapter